Clinical factors associated with outcome in metastatic renal cell carcinoma patients treated with VEGF-targeted therapy

被引：0
|
作者：
Golshayan, A. [1 ]
Choueiri, T. K. [1 ]
Elson, P. [1 ]
Garcia, J. A. [1 ]
Khaswneh, M. [1 ]
Usman, S. [1 ]
Tamaskar, I. [1 ]
Wood, L. [1 ]
Rini, B. I. [1 ]
Bukowski, R. M. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy
    Choueiri, T. K.
    Regan, M. M.
    Brick, A. J.
    Clement, J. M.
    Kwabi, C.
    Shah, K.
    Amato, A.
    McDermott, D. F.
    Atkins, M. B.
    Signoretti, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma
    Funakoshi, Tomohiro
    Lee, Chung-Han
    Hsieh, James J.
    CANCER TREATMENT REVIEWS, 2014, 40 (04) : 533 - 547
  • [33] EVEROLIMUS IN METASTATIC RENAL CANCER CARCINOMA PROGRESSED ON VEGF-TARGETED THERAPY: A SINGLE-CENTRE EXPERIENCE
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Caruso, Salvatore
    Cipriani, Greta
    Diacciati, Sara
    Cerullo, Carmine
    Santomaggio, Carmine
    Carini, Marco
    Mazzanti, Roberto
    ANTICANCER RESEARCH, 2010, 30 (04) : 1473 - 1473
  • [34] The REACT Expanded-access Program of Everolimus in Patients With Metastatic Renal Cell Carcinoma Refractory to VEGF-targeted Therapy: Subgroup Analyses by Prior Therapy
    Larkin, J.
    Blank, C.
    Bono, P.
    Kim, D.
    Panneerselvam, A.
    Gruenwald, V.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S519 - S519
  • [35] The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer
    Sharpe, Kevin
    Stewart, Grant D.
    Mackay, Alan
    Van Neste, Christophe
    Rofe, Charlotte
    Berney, Dan
    Kayani, Irfan
    Bex, Axel
    Wan, Elaine
    O'Mahony, Fiach C.
    O'Donnell, Marie
    Chowdhury, Simon
    Doshi, Rukma
    Ho-Yen, Colan
    Gerlinger, Marco
    Baker, Dawn
    Smith, Neil
    Davies, Barry
    Sahdev, Anju
    Boleti, Ekaterini
    De Meyer, Tim
    Van Criekinge, Wim
    Beltran, Luis
    Lu, Yong-Jie
    Harrison, David J.
    Reynolds, Andrew R.
    Powles, Tom
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6924 - 6934
  • [36] The impact of active smoking on survival outcome in metastatic renal cell carcinoma patients treated with targeted therapy.
    Li, Haoran
    Kroeger, Nils
    de Velasco, Guillermo
    Donskov, Frede
    Sim, Hao-Wen
    Wells, Connor
    Stukalin, Igor
    Agarwal, Neeraj
    Parekh, Hiral D.
    Rini, Brian I.
    Knox, Jennifer J.
    Pantuck, Allan J.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [37] Choi Response Criteria for Prediction of Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapies
    Potthast, S.
    Hess, V.
    Schmidt, N.
    Zumbrunn, T.
    Bongartz, G. M.
    Rothermundt, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S169 - S169
  • [38] HandFoot Skin Reaction is Associated with the Clinical Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib
    Nakano, Kazuhiko
    Komatsu, Kenji
    Kubo, Taro
    Natsui, Shinsuke
    Nukui, Akinori
    Kurokawa, Shinsuke
    Kobayashi, Minoru
    Morita, Tatsuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (10) : 1023 - 1029
  • [39] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Biasoni, D.
    Testa, I.
    Porcu, L.
    De Braud, F.
    BRITISH JOURNAL OF CANCER, 2012, 107 (08) : 1227 - 1232
  • [40] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    G Procopio
    E Verzoni
    R Iacovelli
    D Biasoni
    I Testa
    L Porcu
    F De Braud
    British Journal of Cancer, 2012, 107 : 1227 - 1232
12345